---
title: "Migalastat - Fabry'S Disease"
sidebar: mydoc_sidebar
permalink: db05018-mesh-d000795-1.html
toc: false 
---


Path ID: `DB05018_MESH_D000795_1`
{% include image.html url="images/db05018-mesh-d000795-1.png" file="db05018-mesh-d000795-1.png" alt="db05018-mesh-d000795-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C090092 | migalastat | Drug |
| UniProt:O95477 | Alpha-galactosidase A | Protein |
| GO:0030149 | sphingolipid catabolic process | BiologicalProcess |
| CHEBI:26739 | sphingolipid | ChemicalSubstance |
| MESH:D000795 | Fabry's disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Migalastat | INCREASES FOLDING OF | Alpha-Galactosidase A |
| Alpha-Galactosidase A | POSITIVELY REGULATES | Sphingolipid Catabolic Process |
| Sphingolipid Catabolic Process | DECREASES ABUNDANCE OF | Sphingolipid |
| Sphingolipid | POSITIVELY CORRELATED WITH | Fabry'S Disease |
|---------|-----------|---------|

Comment: Migalastat is a pharmacological chaperone, helping misfolidng Alpha-galactosidase A proteins in Fabry disease patients to fold correctly and play its physiological role.

Reference: 
  - [https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL110458](https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL110458)
  - [https://go.drugbank.com/drugs/DB05018](https://go.drugbank.com/drugs/DB05018)
  - [https://en.wikipedia.org/wiki/Pharmacological_chaperone](https://en.wikipedia.org/wiki/Pharmacological_chaperone)
